Comparison Of Inflammatory Control And Safety By Timing Of Doxycycline-Azithromycin Dual Therapy In Pediatric Mycoplasmal Pneumonia
View Full Paper
Ask AI
Bookmark
Share
Discussion
Loading...
Member takes
Overview
Comparison of timing effects on clinical efficacy and safety in pediatric mycoplasmal pneumonia shows shorter symptom duration with doxycycline therapy within 72 hours, indicating dual therapy benefit
Key Points
Shorter symptom improvement time observed in the group receiving doxycycline within 72 hours after azithromycin administration.
Both treatment groups showed no significant differences in clinical efficacy or pulmonary function results (P>0.05).
Long-term doxycycline use increased safety by decreasing inflammatory and stress responses, alongside lower complication rates (P<0.05).
Study highlights the importance of timing in antibiotic therapy for effective inflammatory control in pediatric mycoplasmal pneumonia.